GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » EV-to-EBITDA

Megasoft (NSE:MEGASOFT) EV-to-EBITDA : 22.75 (As of May. 06, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Megasoft EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Megasoft's enterprise value is ₹6,736.25 Mil. Megasoft's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹296.09 Mil. Therefore, Megasoft's EV-to-EBITDA for today is 22.75.

The historical rank and industry rank for Megasoft's EV-to-EBITDA or its related term are showing as below:

NSE:MEGASOFT' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.08   Med: 6.44   Max: 65.7
Current: 22.75

During the past 13 years, the highest EV-to-EBITDA of Megasoft was 65.70. The lowest was 1.08. And the median was 6.44.

NSE:MEGASOFT's EV-to-EBITDA is ranked worse than
71.35% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.53 vs NSE:MEGASOFT: 22.75

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-06), Megasoft's stock price is ₹72.50. Megasoft's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-0.310. Therefore, Megasoft's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Megasoft EV-to-EBITDA Historical Data

The historical data trend for Megasoft's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft EV-to-EBITDA Chart

Megasoft Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.15 5.22 6.97 33.91 12.62

Megasoft Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.05 12.62 7.54 15.92 16.77

Competitive Comparison of Megasoft's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Megasoft's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Megasoft's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Megasoft's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Megasoft's EV-to-EBITDA falls into.



Megasoft EV-to-EBITDA Calculation

Megasoft's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6736.253/296.086
=22.75

Megasoft's current Enterprise Value is ₹6,736.25 Mil.
Megasoft's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹296.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Megasoft  (NSE:MEGASOFT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Megasoft's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=72.50/-0.310
=At Loss

Megasoft's share price for today is ₹72.50.
Megasoft's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.310.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Megasoft EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Megasoft's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Megasoft (NSE:MEGASOFT) Business Description

Traded in Other Exchanges
Address
Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081
Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft (NSE:MEGASOFT) Headlines

No Headlines